Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5673 | 1523 | 35.9 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1625 | 6488 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PRIMARY SCLEROSING CHOLANGITIS | Author keyword | 326 | 53% | 28% | 428 |
2 | SCLEROSING CHOLANGITIS | Author keyword | 16 | 24% | 4% | 57 |
3 | NORWEGIAN PSC | Address | 15 | 50% | 1% | 22 |
4 | IDIOPATHIC ADULTHOOD DUCTOPENIA | Author keyword | 15 | 88% | 0% | 7 |
5 | NORWEGIAN PSC TRANSPLANTAT MED | Address | 14 | 100% | 0% | 7 |
6 | SECT GASTROENTEROL TRANSPLANTAT MED | Address | 12 | 86% | 0% | 6 |
7 | DOMINANT STRICTURE | Author keyword | 9 | 83% | 0% | 5 |
8 | DOMINANT STENOSIS | Author keyword | 6 | 100% | 0% | 4 |
9 | SECONDARY SCLEROSING CHOLANGITIS | Author keyword | 6 | 50% | 1% | 8 |
10 | PSC | Author keyword | 4 | 18% | 1% | 22 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DOSE URSODEOXYCHOLIC ACID | 82 | 60% | 6% | 89 |
2 | CLINICOPATHOLOGIC FEATURES | 63 | 70% | 3% | 52 |
3 | PSC IBD | 38 | 93% | 1% | 14 |
4 | DOMINANT STRICTURES | 21 | 78% | 1% | 14 |
5 | PERICHOLANGITIS | 18 | 89% | 1% | 8 |
6 | PULSE METHOTREXATE THERAPY | 17 | 100% | 1% | 8 |
7 | DETECTING CHOLANGIOCARCINOMA | 15 | 77% | 1% | 10 |
8 | DUCT STENOSES | 15 | 77% | 1% | 10 |
9 | CHILD PUGH CLASSIFICATION | 12 | 59% | 1% | 13 |
10 | HEPATOBILIARY CARCINOMA | 11 | 60% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diagnosis and Management of Primary Sclerosing Cholangitis | 2010 | 206 | 175 | 73% |
ACG Clinical Guideline: Primary Sclerosing Cholangitis | 2015 | 1 | 135 | 64% |
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management | 2013 | 35 | 162 | 64% |
PRIMARY SCLEROSING CHOLANGITIS | 1995 | 345 | 93 | 81% |
Cancer Surveillance in Patients With Primary Sclerosing Cholangitis | 2011 | 43 | 95 | 64% |
Diagnosis and classification of primary sclerosing cholangitis | 2014 | 5 | 75 | 83% |
Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer | 2006 | 90 | 85 | 75% |
The challenges in primary sclerosing cholangitis - Aetiopathogenesis, autoimmunity, management and malignancy | 2008 | 53 | 179 | 70% |
Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies | 2014 | 5 | 60 | 60% |
Incidence of Primary Sclerosing Cholangitis: a Systematic Review and Meta-Analysis | 2011 | 33 | 36 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NORWEGIAN PSC | 15 | 50% | 1.4% | 22 |
2 | NORWEGIAN PSC TRANSPLANTAT MED | 14 | 100% | 0.5% | 7 |
3 | SECT GASTROENTEROL TRANSPLANTAT MED | 12 | 86% | 0.4% | 6 |
4 | CANC MED SURG TRANSPLANTAT | 4 | 23% | 1.0% | 15 |
5 | SECT GASTROENTEROL CANC MED SURG TRANSPLANT | 3 | 100% | 0.2% | 3 |
6 | CLIN SPECIALIZED MED SURG | 2 | 32% | 0.4% | 6 |
7 | CANC SURG TRANSPLANTATOSLO UNIV HOSP | 2 | 67% | 0.1% | 2 |
8 | GASTROENTEROL HEPATOL IKE | 2 | 67% | 0.1% | 2 |
9 | NORWEGIAN PRIMARY SCLEROSING CHOLANGITIS | 2 | 67% | 0.1% | 2 |
10 | SECT HEPATOPANCREAT BILIARY SURG | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000122698 | PRIMARY BILIARY CIRRHOSIS//ANTIMITOCHONDRIAL ANTIBODIES//RHEUMATOL ALLERGY CLIN IMMUNOL |
2 | 0.0000118510 | INTRADUCTAL ULTRASONOGRAPHY//CHOLANGIOSCOPY//DIRECT PERORAL CHOLANGIOSCOPY |
3 | 0.0000103817 | AUTOIMMUNE HEPATITIS//AUTOIMMUNE LIVER DISEASE//DE NOVO AUTOIMMUNE HEPATITIS |
4 | 0.0000098838 | ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES//ASCA//ANTI SACCHAROMYCES CEREVISIAE ANTIBODY |
5 | 0.0000088233 | URSODEOXYCHOLIC ACID//TAUROURSODEOXYCHOLIC ACID//TAUROURSODEOXYCHOLATE |
6 | 0.0000079284 | EOSINOPHILIC CYSTITIS//EOSINOPHILIC CHOLANGITIS//EOSINOPHILIC CHOLECYSTITIS |
7 | 0.0000076715 | SURVEILLANCE COLONOSCOPY//DALM//DYSPLASIA ASSOCIATED LESION OR MASS |
8 | 0.0000070966 | AUTOIMMUNE PANCREATITIS//IGG4 RELATED DISEASE//IGG4 |
9 | 0.0000066107 | CHOLANGIOCARCINOMA//HILAR CHOLANGIOCARCINOMA//INTRAHEPATIC CHOLANGIOCARCINOMA |
10 | 0.0000062769 | EXTRAINTESTINAL MANIFESTATIONS//EXTRAINTESTINAL MANIFESTATION//LUNG BEING CONNECTED WITH LARGE INTESTINE |